Literature DB >> 2644021

Role of the virology laboratory in diagnosis and management of patients with central nervous system disease.

T Chonmaitree1, C D Baldwin, H L Lucia.   

Abstract

A number of viruses cause acute central nervous system disease. The two major clinical presentations are aseptic meningitis and the less common meningoencephalitis. Clinical virology laboratories are now more widely available than a decade ago; they can be operated on a modest scale and can be tailored to the needs of the patients they serve. Most laboratories can provide diagnostic information on diseases caused by enteroviruses, herpesviruses, and human immunodeficiency virus. Antiviral therapy for herpes simplex virus is now available. By providing a rapid diagnostic test or isolation of the virus or both, the virology laboratory plays a direct role in guiding antiviral therapy for patients with herpes simplex encephalitis. Although there is no specific drug available for enteroviruses, attention needs to be paid to these viruses since they are the most common cause of nonbacterial meningitis and the most common pathogens causing hospitalization for suspected sepsis in young infants in the United States during the warm months of the year. When the virology laboratory maximizes the speed of viral detection or isolation, it can make a significant impact on management of these patients. Early viral diagnosis benefits patients with enteroviral meningitis, most of whom are hospitalized and treated for bacterial sepsis or meningitis or both; these patients have the advantage of early withdrawal of antibiotics and intravenous therapy, early hospital discharge, and avoidance of the risks and costs of unnecessary tests and treatment. Enteroviral infection in young infants also is a risk factor for possible long-term sequelae. For compromised patients, the diagnostic information helps in selecting specific immunoglobulin therapy. Good communication between the physician and the laboratory will result in the most benefit to patients with central nervous system viral infection.

Entities:  

Mesh:

Year:  1989        PMID: 2644021      PMCID: PMC358097          DOI: 10.1128/CMR.2.1.1

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  144 in total

1.  Central nervous system syndromes of "vital" etiology. A study of 713 cases.

Authors:  H M MEYER; R T JOHNSON; I P CRAWFORD; H E DASCOMB; N G ROGERS
Journal:  Am J Med       Date:  1960-08       Impact factor: 4.965

2.  Segmental zoster paresis--a disease profile.

Authors:  J E Thomas; F M Howard
Journal:  Neurology       Date:  1972-05       Impact factor: 9.910

3.  Evaluation of an enzyme-linked immunosorbent assay for the detection of herpes simplex virus antigen.

Authors:  M A Morgan; T F Smith
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

4.  Rapid detection of herpes simplex virus using a combination of human fibroblast cell cultures and peroxidase-antiperoxidase staining.

Authors:  M P Meyer; A J Amortegui
Journal:  Am J Clin Pathol       Date:  1984-01       Impact factor: 2.493

5.  Rapid detection of herpes simplex virus in clinical specimens with human embryonic lung fibroblast and primary rabbit kidney cell cultures.

Authors:  D R Callihan; M A Menegus
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

6.  Detection of enteroviruses by spot hybridization.

Authors:  T Hyypiä; P Stålhandske; R Vainionpää; U Pettersson
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

7.  Rapid diagnosis of herpes simplex virus infections by enzyme-linked immunosorbent assay.

Authors:  S A Land; I J Skurrie; G L Gilbert
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

8.  Central nervous system echovirus infection in Bruton's X-linked hypogammaglobulinemia.

Authors:  R L Prentice; A G Dalgleish; P A Gatenby; R H Loblay; S Wade; N Kappagoda; A Basten
Journal:  Aust N Z J Med       Date:  1985-08

9.  Alpha-interferon responses in cerebrospinal fluid of patients with suspected meningitis.

Authors:  D O Ho-Yen; D Carrington
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

10.  Assessment of an immunoassay for interferon-alpha in cerebrospinal fluid as a diagnostic aid in infections of the central nervous system.

Authors:  R J Abbott; I Bolderson; P J Gruer
Journal:  J Infect       Date:  1987-09       Impact factor: 6.072

View more
  14 in total

1.  New reverse transcription-PCR assay for rapid and sensitive detection of enterovirus genomes in cerebrospinal fluid specimens of patients with aseptic meningitis.

Authors:  Jérôme Jacques; Jocelyne Carquin; Véronique Brodard; Hélène Moret; Dorine Lebrun; Maude Bouscambert; Jacques Motte; Gérard Rémy; Laurent Andréoletti
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 2.  Laboratory diagnosis of bacterial meningitis.

Authors:  L D Gray; D P Fedorko
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory.

Authors:  S J Read; K J Jeffery; C R Bangham
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Use of monoclonal antibodies to identify serotypes of enterovirus isolates.

Authors:  A S Rigonan; L Mann; T Chonmaitree
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

5.  Detection by PCR of enteroviruses in cerebrospinal fluid during a summer outbreak of aseptic meningitis in Switzerland.

Authors:  M Gorgievski-Hrisoho; J D Schumacher; N Vilimonovic; D Germann; L Matter
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 6.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Rapid diagnosis of enterovirus infection by a new one-step reverse transcription-PCR assay.

Authors:  H H Kessler; B Santner; H Rabenau; A Berger; A Vince; C Lewinski; B Weber; K Pierer; D Stuenzner; E Marth; H W Doerr
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

8.  Enterovirus meningitis in Greece from 2003-2005: diagnosis, CSF laboratory findings, and clinical manifestations.

Authors:  Kamal Dumaidi; Filanthi Frantzidou; Anna Papa; Eudoxia Diza; Antonis Antoniadis
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

9.  Evaluation of a commercially available reverse transcription-PCR assay for diagnosis of enteroviral infection in archival and prospectively collected cerebrospinal fluid specimens.

Authors:  F Pozo; I Casas; A Tenorio; G Trallero; J M Echevarria
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control.

Authors:  Marcel Beld; René Minnaar; Jan Weel; Cees Sol; Marjolein Damen; Harry van der Avoort; Pauline Wertheim-van Dillen; Alex van Breda; René Boom
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.